WE HAVE GREAT NEWS!! Dynaris' Apogee has received F.D.A. 510(k) Clearance to market in the U.S.

Now we can focus on marketing and production of the Apogee, the world’s only dual nasal selective oxygen delivery device for patients on portable oxygen. With the 510(k) Clearance, which is in addition to the EUA (Emergency Use Authorization) awarded earlier this year, we now have clearance beyond the current state of emergency.

We are also in development of a second product. This utilizes the same technology as the Apogee but for a broader patient market. We believe we can have this on the market as early as the first quarter of next year.

Thank you so much for your ongoing trust and support.

Providing Innovative Oxygen Therapy Technology

Did you know that almost half of the oxygen delivered by a nasal cannula is wasted? Research showed that the unilateral nasal resistance blocks oxygen from entry, meaning patients do not receive the liter flow prescribed to them.

Don’t waste your breath. Dynaris in Chesterfield, MO presents a new technology specially designed to address this dilemma.


Who We Are

We are a developer and manufacturer of oxygen therapy technologies. Our technologies respond and adapt to changes in nasal resistance.

8-Hour Patient Breathing